CLLS
Cellectis S.A.
$2.98
-$0.10(-3.25%)
36
Overall
--
Value
45
Tech
28
Quality
Market Cap
$221.40M
Volume
163.49K
52W Range
$1.35 - $5.48
Target Price
$7.60
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Total Revenue | $25.2M | $12.7M | $15.2M | $73.9M | $57.3M | $19.2M | $755.0K | $41.5M | $6.6M | ||
| Total Revenue | $25.2M | $12.7M | $15.2M | $51.1M | $57.3M | $19.2M | $-7.7M | $7.7M | $6.6M | ||
| COST OF GOODS SOLD | |||||||||||
| Cost of Revenue | $2.6M | $2.7M | $11.4M | $-2.0M | $-31.4M | $-1.8M | $737.0K | $-41.5M | $-72.9M | ||
| GROSS PROFIT | |||||||||||
| Gross Profit | $25.2M | $10.0M | $3.8M | $37.7M | $25.9M | $17.4M | $-8.4M | $49.2M | $79.6M | ||
| OPERATING EXPENSES | |||||||||||
| Operating Expenses | $144.9M | $127.6M | $135.1M | $148.7M | $174.6M | $132.8M | $104.5M | $109.6M | $113.3M | ||
| Research & Development | $79.2M | $76.6M | $92.0M | $87.0M | $136.7M | $97.5M | $87.6M | $90.5M | $93.5M | ||
| Research Expense | $79.2M | $76.6M | $92.0M | $87.0M | $136.7M | $97.5M | $50.8M | -- | -- | ||
| Selling, General & Administrative | $63.0M | $51.1M | $43.0M | $61.7M | $37.9M | $17.5M | $16.8M | $19.1M | $19.8M | ||
| Selling & Marketing Expenses | $44.8M | $51.1M | $43.0M | $61.7M | $37.9M | $17.5M | $16.8M | $19.1M | $19.8M | ||
| General & Administrative Expenses | $18.3M | -- | -- | -- | -- | -- | $9.5M | -- | -- | ||
| Salaries & Wages | $-48.9M | $-34.6M | -- | -- | -- | $17.8M | $44.2M | -- | -- | ||
| Depreciation & Amortization | $-3.4M | $-2.4M | $-6.9M | $-9.8M | -- | $-11.2M | -- | -- | -- | ||
| Depreciation & Amortization | $-3.4M | $-2.4M | $-6.9M | $-9.8M | -- | $-11.2M | -- | -- | -- | ||
| Amortization | $-231.0K | $-217.0K | $-174.0K | $-206.0K | -- | $-492.0K | -- | -- | -- | ||
| Other Operating Expenses | $2.6M | $2.7M | $-2.1M | $-2.1M | -- | $-1.8M | $1.3M | -- | -- | ||
| OPERATING INCOME | |||||||||||
| Operating income | $-119.7M | $-117.6M | $-131.3M | $-111.0M | $-148.6M | $-115.4M | $-112.9M | $-60.4M | $-33.7M | ||
| EBITDA | $-100.3M | $-164.7M | $-210.4M | $-168.3M | $-222.7M | $-186.7M | $-71.6M | $4.7M | $3.1M | ||
| NON-OPERATING ITEMS | |||||||||||
| Interest Expense (Non-Operating) | -- | $-39.0K | $-3.0K | $-43.0K | -- | $-371.0K | $40.6M | $21.6M | $51.1M | ||
| Intinc | $7.3M | $20.6M | $12.0M | $5.5M | $13.2M | $8.9M | $21.5M | $44.4M | $16.1M | ||
| Net Non-Operating Interest Income/Expense | $7.3M | $20.6M | $12.0M | $5.5M | $13.2M | $8.9M | $-19.2M | $22.8M | $-34.9M | ||
| Other Income/Expense | $-8.8M | $70.0M | $98.0M | $73.0M | $103.9M | $98.2M | $-1.3M | $-849.0K | $-638.0K | ||
| Other Special Charges | $8.5M | $8.7M | $7.8M | $-72.6M | $9.8M | $6.6M | $1.3M | $849.0K | $638.0K | ||
| SPECIAL ITEMS | |||||||||||
| Special Income Charges | -- | $31.0K | -- | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||||||
| EBIT | $-103.7M | $-167.1M | $-217.3M | $-178.1M | $-239.3M | $-205.1M | $-90.1M | $-15.1M | $-17.0M | ||
| Pre-Tax Income | $-103.7M | $-167.0M | $-217.3M | $-178.6M | $-239.3M | $-204.7M | $-130.7M | $-36.8M | $-68.0M | ||
| INCOME TAX | |||||||||||
| Tax Provision | -- | -- | -- | -- | -- | $98.6M | $371.0K | -- | $-423.0K | ||
| NET INCOME | |||||||||||
| Net Income | $-108.0M | $-176.7M | $-230.4M | $-195.0M | $-250.2M | $-326.6M | $-130.1M | $-36.8M | $-67.6M | ||
| Net Income (Continuing Operations) | $-108.0M | $-176.7M | $-230.4M | $-195.0M | $-250.2M | $-326.6M | $-131.1M | $-36.8M | $-67.6M | ||
| Net Income (Discontinued Operations) | $-108.0M | $-176.7M | $-230.4M | $-195.0M | $-250.2M | $-326.6M | $-130.1M | $-36.8M | $-67.6M | ||
| Net Income (Common Stockholders) | $-108.0M | $-176.7M | $-230.4M | $-195.0M | $-250.2M | $-326.6M | $-130.1M | $-36.8M | $-67.6M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-96.1M | $-36.4M | $-68.4M | ||
| TOTALS | |||||||||||
| Total Expenses | $142.3M | $124.9M | $123.7M | $146.7M | $143.2M | $131.0M | $105.2M | $68.1M | $40.4M | ||
| SHARE & EPS DATA | |||||||||||
| Average Shares Outstanding | $35.7M | $40.8M | $42.4M | $102.1M | $98.1M | $45.5M | $57.0M | $90.6M | -- | ||
| Average Shares Outstanding (Diluted) | $38.8M | $91.5M | $95.6M | $102.1M | $98.1M | $140.2M | $57.0M | $90.6M | -- | ||
| Shares Outstanding | $36.0M | $42.4M | $42.5M | $42.8M | $45.5M | $45.7M | $72.6M | $72.6M | $57.0M | ||
| Basic EPS | $-2.78 | $-1.93 | $-2.41 | $-1.91 | $-2.55 | $-2.33 | $-1.77 | $-0.41 | -- | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-1.77 | $-0.41 | -- | ||
| Diluted EPS | $-2.78 | $-1.93 | $-2.41 | $-1.91 | $-2.55 | $-2.33 | $-1.77 | $-0.41 | -- | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-1.77 | $-0.41 | -- | ||
| OTHER METRICS | |||||||||||
| Acquired In Process Rn D | -- | $31.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | -- | $31.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | -- | -- | -- | -- | -- | $-0.16 | -- | -- | -- | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | -- | $-0.16 | -- | -- | -- | ||
| Earnings from equity interest | -- | -- | $-91.0K | -- | $511.0K | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | $-91.0K | -- | $511.0K | -- | -- | -- | -- | ||
| Fees | -- | $2.1M | $1.8M | $2.1M | -- | $686.0K | -- | -- | -- | ||
| Gain On Sale Of Business | $232.0K | -- | $-102.1M | $-467.0K | -- | $-106.1M | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | -- | -- | $-15.3M | -- | -- | -- | ||
| Marketing Expense | -- | -- | -- | $17.5M | -- | -- | -- | -- | -- | ||
| Minority Interests | $-4.3M | $-9.6M | $-13.1M | $-16.4M | $-10.9M | $-7.9M | $-7.4M | -- | -- | ||
| Net Income Discontinuous Operations | -- | -- | $-115.2M | $-97.5M | -- | $-15.3M | $8.4M | -- | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | -- | $737.0K | $-41.5M | $-72.9M | ||
| Other Gand A | $18.3M | -- | -- | -- | -- | -- | $9.5M | -- | -- | ||
| Other Write Down | -- | -- | $3.6M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $44.8M | $51.1M | $43.0M | $44.2M | $37.9M | $17.5M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLLS | $2.98 | -3.2% | 163.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |